Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.
about
Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative reviewWhen to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern AfricaCosts of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'IvoireBUILDING NEW KNOWLEDGESevere morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009.Universal HIV screening at postnatal points of care: which public health approach for early infant diagnosis in Côte d'Ivoire?Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.Mortality and Loss to Follow up Before Initiation of Antiretroviral Therapy Among HIV-Infected Children Eligible for HIV Treatment.The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008.HIV prevalence and impact on renutrition in children hospitalised for severe malnutrition in Niger: an argument for more systematic screening.Linkage, initiation and retention of children in the antiretroviral therapy cascade: an overview.Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected childrenPoor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagementPredictors of mortality among children on Antiretroviral Therapy at a referral hospital, Northwest Ethiopia: a retrospective follow up study.Retention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review.Access to HIV prevention and care for HIV-exposed and HIV-infected children: a qualitative study in rural and urban Mozambique.Temporal trends in the characteristics of children at antiretroviral therapy initiation in southern Africa: the IeDEA-SA CollaborationImplementation and Operational Research: Risk Factors of Loss to Follow-up Among HIV-Positive Pediatric Patients in Dar es Salaam, Tanzania.Implementation of antiretroviral therapy guidelines for under-five children in Tanzania: translating recommendations into practice.Mortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West AfricaOutcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.Health care resource utilization in untreated HIV-infected children in a pediatric programme, Abidjan, Côte d'Ivoire, 2004-2009.Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013.Notification of HIV status disclosure and its related factors in HIV-infected adolescents in 2009 in the Aconda program (CePReF, CHU Yopougon) in Abidjan, Côte d'Ivoire, The PRADO-CI Study.Mortality and loss to follow-up in the first year of ART: Malawi national ART programmeHigh retention among HIV-infected children in Rwanda during scale-up and decentralization of HIV care and treatment programs, 2004 to 2010.Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania.Implementation and Operational Research: An Integrated and Comprehensive Service Delivery Model to Improve Pediatric and Maternal HIV Care in Rural Africa.Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia.Morbidity and health care resource utilization in HIV-infected children after antiretroviral therapy initiation in Côte d'Ivoire, 2004-2009.Reasons for hospitalization in HIV-infected children in West AfricaMortality and clinical outcomes in children treated with antiretroviral therapy in four African vertical programmes during the first decade of paediatric HIV care, 2001-2010.Adherence to the follow-up of the newborn exposed to syphilis and factors associated with loss to follow-up.Task-sharing with nurses to enhance access to HIV treatment in Côte d'Ivoire.Loss to follow-up among children in pre-ART care under the National AIDS Programme, Tamil Nadu, South India.Pediatric HIV care and treatment services in Tanzania: implications for survival.Predictors of Mortality and Mortality Rate in a Cohort of Children Living with HIV from India.Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.
P2860
Q26783160-724CBA46-EFAB-4F61-8DAF-B6B500B35C05Q28535251-83BA4DF5-C97E-494B-A490-E0744706CBBDQ28554853-AF165E68-D356-4035-BB31-3A85CE5882C4Q29248576-DCF5734B-5BEB-4520-8ED2-42C65ACCD732Q31020587-2392D106-5F1E-4FBC-B9E4-BC55409B4428Q31130109-B722D126-EED4-4888-A0D0-E43CC3B93030Q33722976-F1C90ECB-708C-4097-86DB-BDCDEF0B28C5Q33851192-377600B3-925F-4FBB-A418-0AB716562EF9Q33939293-9D082AA8-BEE2-4B84-ABAB-6037784E1B0EQ33947235-F2D83C7B-E3A3-4E1B-A9C5-560A436AB83CQ33987881-30B4DE03-1772-489A-85D0-C1543959A6D4Q34011979-04B1685D-DA21-43E9-A6A2-E8181DBD40B6Q34214526-38463B15-E043-4CE2-B1C9-5BEEB700F6F7Q34374033-F8EEFA60-D96E-46A9-B561-320415090C5EQ34435987-6513E143-85EE-484C-80F5-E31CF122C0FCQ34598728-6E873A34-809D-407D-9C1F-5A58DFC071D1Q34695141-F476D566-2138-429E-A9AE-C89C78B0437FQ35074354-09353CF0-DB83-4BB6-87D6-C371F1BC4F39Q36294353-2B245B83-F902-44E9-AD4B-E35FCE5B582AQ36389935-5E1DF89E-AC96-4F88-8ED2-602F671B46C4Q36420723-47A53C91-D5AF-4324-9779-B88CB892CF9CQ36565583-63DBFD90-EBA3-4F36-810A-F5065012C9B2Q36566897-4187FD07-40C3-420A-8E59-C270F8C7258EQ36597730-AF6426FB-A218-4A4B-B2C1-1B00AE9695D2Q36729941-B06D8766-CFAB-43BF-84F2-2B680580D3E6Q36942307-BAE8B0EA-768F-4C02-A777-F770547607A4Q37262727-E733B7F6-9012-47D5-8B31-D18ABB97CE62Q37343714-9B2C13B1-B0EB-4978-9D8E-B2D8DBFCF275Q37390909-3D382C99-B62E-42C0-9E85-10BFBD11AF70Q37520078-5DA756A9-5FEC-4736-81DF-4B77A11DA49EQ37664377-4423A1FA-4D7E-425D-8D88-FB24D534055BQ37695745-662EFD6A-5E3E-463C-9BBC-53B1BF091EA3Q37723712-E7A2F21F-8385-4AF7-868D-B43C53C19063Q38851825-94BE8839-275E-4ACA-9DBC-E62899C9612DQ38986703-0BDF3660-4B60-407D-896D-2548E01C4BDEQ39013142-CA9BA5AE-F46A-4244-B26A-049D49814C9DQ39427337-6D33195D-1693-49DD-93FB-ED16B28E98F1Q39477797-A4992070-E076-4794-9CC9-F0BD5F9F67C2Q39967333-C2C186C1-FFBB-4A97-A5E5-2CE541AEABA9Q40223405-892A0755-061E-4A4D-A04B-13E1FEF06A2A
P2860
Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Scaling up antiretroviral ther ...... urvival and loss to programme.
@ast
Scaling up antiretroviral ther ...... urvival and loss to programme.
@en
type
label
Scaling up antiretroviral ther ...... urvival and loss to programme.
@ast
Scaling up antiretroviral ther ...... urvival and loss to programme.
@en
prefLabel
Scaling up antiretroviral ther ...... urvival and loss to programme.
@ast
Scaling up antiretroviral ther ...... urvival and loss to programme.
@en
P2093
P2860
P356
P1476
Scaling up antiretroviral ther ...... urvival and loss to programme.
@en
P2093
A Kouakoussui
J Duvignac
P Fassinou
T N'Dri-Yoman
X Anglaret
P2860
P304
P356
10.2471/BLT.09.068015
P407
P577
2009-12-21T00:00:00Z